Related Experiment Video
Updated: Aug 5, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Head-to-head comparison of six commercial artificial intelligence algorithms for embryo ploidy risk stratification in
Carla Giménez-Rodríguez1, Blanca Caparrós López-Battú2, Lorena Bori1
1IVIRMA Global Research Alliance, IVIRMA Valencia, Spain; IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Research Question:
Do commercial artificial intelligence (AI)-based embryo assessment algorithms differ in their ability to stratify the risk of embryo ploidy, or do they converge towards a similar level of discrimination despite being developed for different clinical objectives?
Design:
Retrospective cohort study conducted at a single IVF centre, including 1000 blastocysts from 273 patients treated between 2022 and 2023. Embryos were scored using six anonymized commercial AI models (three each of static- or video-based). Ploidy status was determined by trophectoderm biopsy followed by preimplantation genetic testing for aneuploidy (PGT-A). Performance was evaluated using multivariable logistic regression and receiver operating characteristic curves (continuous scores). Euploidy enrichment across within-algorithm score strata and rank concordance (Kendall's τ-b) were assessed, with subgroup analyses by Asociación para el Estudio de la Biología de la Reproducción morphological grade and oocyte age.
Results:
All six algorithms showed moderate discrimination between euploid and aneuploid embryos (area under the curve range 0.713-0.744, overlapping 95% CI), and their continuous scores were significantly associated with ploidy status (all P < 0.001). For each model, higher score strata were associated with progressive enrichment of euploid embryos, despite substantial overlap in score distributions between ploidy groups. Ranking concordance between algorithms was moderate, indicating that embryos prioritized by different systems frequently differed. These patterns were broadly consistent across morphological grades and maternal age strata.
Conclusions:
Across 1000 PGT-A-validated blastocysts, commercial AI embryo assessment algorithms converge towards a shared ceiling of ploidy risk stratification performance. These tools should therefore be interpreted as relative risk stratification systems rather than diagnostic tests. While AI scores may support embryo prioritization when PGT-A cannot be performed, limited concordance across algorithms indicates that the choice of algorithm can influence which embryos are prioritized.
More Related Videos
12:32Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
Published on: September 7, 2021
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022